The AACE/ACE, in contrast to the ADA, provides several monotherapy options that are recommended in the following order according to the strength of each recommendation: metformin, GLP-1 receptor agonist, SGLT-2 inhibitor, DPP-4 inhibitor, thiazolidinedione, -glucosidase inhibitor, and an insulin secretagogue (a sulfonylurea or meglitinide)
(2021) Food sources of selenium and its relationship with chronic diseases, Nutrients , 13 , 1739, Winther, K
How GLP-1 Medication Supports Weight Loss GLP-1 agonists work through several key mechanisms to help patients lose weight
Diabetes Care (2016) 39(2):23141
Outside of confirmed deficiency states, the use of L-carnitine supplements is largely driven by the sports nutrition and weight management market rather than by formal clinical guidance from NICE or the NHS